|
NIDA-FDA Interagency Clinical Outcomes Assessment Working Group (ICOAWG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDA, NCI, OD/DPCPSI/OBSSR
|
The Interagency Clinical Outcomes Assessment Working Group (ICOAWG) facilitates scientific exchange between the National Institutes of Health (NIH) and Federal Drug Administration (FDA) and helps to guide research and stay abreast of new and ongoing clinical trials and measurement approaches being used. There is a focus on standards and use of Clinical Outcome Assessments.
|
|
NIEHS SBIR PHASE IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIEHS
|
This SBIR program uses a cooperative agreement mechanism, including regular consultation with a Steering Committee (SC), to conduct formal validation of alternative test methods. The SCs consist of ICCVAM NICEATM members.
|
|
NIH Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, HRSA
|
NIEHS, NIAID, OD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIBIB
|
The purpose of the ADCC is to facilitate coordination of research across the National Institutes of Health (NIH), federal agencies, professional societies, and patient and advocacy organizations with an interest in autoimmune diseases. The ADCC meets once or twice yearly.
|
|
NIH Common Data Elements Task Force (CDETF)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, FDA, CMS, ASPE, CDC
|
NLM, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODSS, OD/OER, OD/AoU, OD/DPCPSI/ORWH, OD/DPCPSI/SGMRO, OD/ECHO, NIGMS, NIMH, NIMHD
|
The NIH CDE Task Force as a whole provides a trans-NIH communications forum – including COVID-related activities. Through its subgroups, such as the COVID CDE Coordinating Committee and the NIH CDE Governance Committee, the Task Force addresses specific trans-NIH issues like coordination across COVID efforts, NIH CDE governance, etc.
|
|
NIH COVID-19 Treatment Guidelines Panel
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The Panel was formed in March 2020, at the beginning of the COVID-19 pandemic in the US. The Panel includes members from academia and professional societies. Five USG ex-officio members are on the Panel, including representatives from BARDA, CDC, DoD, FDA, and VA. The Panel is responsible for writing and updating guidelines for the treatment of COVID-19
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
OD/OER, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI
|
The National Institutes of Health (NIH) Guide for Grants and Contracts is the official publication for NIH medical and behavioral grant policies, guidelines, and funding opportunities. Other US Department of Health and Human Services agencies also use the Guide to disseminate Funding Opportunity Announcements to its 60,000 subscribers.
|
|
NIH Medical Rehabilitation Coordinating Committee (MRCC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, SAMHSA
|
NICHD, CC, CSR, NCCIH, NCI, NEI, NHLBI, NIA, NIAMS, NIBIB, NIDCD, NIDDK, NIMH, NINDS, NINR
|
Pursuant to Public Law 101-613, the National Institutes of Health (NIH) Director established the Medical Rehabilitation Coordinating Committee. The Coordinating Committee makes recommendations to the National Institute of Child Health and Human Development (NICHD) Director and the Director of the National Center for Medical Rehabilitation Research with respect to the content of the research plan and activities that are carried out in conjunction with other components of NIH and with other Federal Government agencies.
|
|
NIH World AIDS Day
|
Other
|
OASH
|
OD/DPCPSI/OAR, NIAID, NIDA, NINDS, NIMH, NCI, NIAAA, NHLBI, NICHD, OD/DPCPSI/ODP, NLM, CC
|
OAR led coordination and planning for the 2023 NIH World AIDS Day event, which involved a panel discussion followed by a public Q&A session. Representatives from OASH and the White House Office of National AIDS Policy participated in the event by providing opening remarks.
|
|
NIH, HUD, CDC Housing and Health Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/DPCPSI/ODP, NCI, NICHD, NIDDK, NHLBI, NIEHS, NIMHD, NINR, OD/DPCPSI/OBSSR
|
The collaboration between National Institutes Health (NIH), Centers for Disease Control and Prevention (CDC) and Department of Housing and Urban Development (HUD) is focused on identifying housing and health-related research resources, current activities and investments on this topic by each agency, and opportunities for collaboration to advance housing and health research. In 2020, a portfolio analysis was conducted of NIH and CDC applications and funded research pertaining to housing and health.
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group (ICOAWG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, CC, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/DPCPSI/OBSSR, OD/DPCPSI/SGMRO
|
The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research.
|